Sorrento (SRNE) Stock Has Over 700% Upside Potential, Says Analyst

Can you feel the ground moving beneath your feet? Shares of Sorrento Therapeutics (SRNE) skyrocket 70% today after the small drug maker were made an offer they could, apparently, refuse. The biotech announced it received an unsolicited proposal by two biopharmaceutical companies to acquire all the company’s issued and outstanding shares, in cash, for a price between $3 and $5 per share. After consulting with the company’s advisors, the board rejected the offer on the basis the deal significantly undervalued the biotech and would be against stockholders’ interests. Sorrento believes its immuno-oncology products have short- and long-term value and has …read more

Source:: Yahoo Finance

      

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.